Find a clinical trial

Filters
Trials
Department
Principal Investigator
Sponsor
RG0111002
A randomized, open-label, Phase 3 study of telaprevir administered twice daily or every 8 hours in combination with pegylated interferon alfa-2a and ribavirin in treatment-naïve subjects with genotype 1 chronic hepatitis C virus infection
Principle Investigator
Scott, John D.
Contact
Nguyen, Peter (Huy Duc)
phnmedic@uw.edu (206) 744-3402
RG1710060
A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
Principle Investigator
Chiorean, E. Gabriela (Gabi)
Contact
Basse, Sarah
sbasse@fredhutch.org (206) 667-4195
RG1810008
Patient Outcomes 6 and 12 Months After ALTA, OMEGA, and EDEN ARDS Network Trials
Principle Investigator
Hough, Catherine (Terri)
Contact
Gundel, Stephanie
sgundel@uw.edu (206) 744-7720
RG1711007
AN OPEN LABEL, MULTICENTER EXTENSION STUDY OF TRASTUZUMAB MCC DM1 (T-DM1) ADMINISTERED AS A SINGLE AGENT OR IN COMBINATION WITH OTHER ANTI-CANCER THERAPIES IN PATIENTS PREVIOUSLY TREATED WITH THE EQUIVALENT T-DM1 REGIMEN IN A GENENTECH AND/OR F. HOFFMANN-
Principle Investigator
Gralow, Julie
Contact
O’Connor, Donielle
doconnor@seattlecca.org (206) 606-7427
RG7213001
Dynamic changes in the ocular surface microbiome
Principle Investigator
Van Gelder, Russell
Contact
Luttrell, Ian
luttri@uw.edu (206) 520-8305
RG0411001
Intraoperative injection of bone marrow-derived stem cells into hearts of patients with end-stage ischemic cardiomyopathy undergoing placement of left ventricular assist device
Principle Investigator
Stempien-Otero, April
Contact
Steffes, Susanne
steffes@uw.edu (206) 616-9054
RG1813000
Assessment of Airway Inflammatory Cells by Sputum Induction
Principle Investigator
Hallstrand, Teal
Contact
Hallstrand, Teal
tealh@uw.edu (206) 543-3166
RG1813005
A phase 2, randomized, double blind, placebo-controlled study of AeroVanc for the treatment of persistent Methicillin-resistant Staphylococcus aureus lung infection in Cystic Fibrosis patients
Principle Investigator
Aitken, Moira
Contact
Blissell, Rebecca (Reba)
blissr@uw.edu (206) 616-8723
RG1715044
Biologic tissue effect of sipuleucel-T on metastatic castration-resistant prostate cancer
Principle Investigator
Yu, Evan
Contact
Crowder, Kelly M.
kcrowder@seattlecca.org (206) 606-7486
RG1313007
An open label, 52-week, safety and tolerability extension to a randomized, double-blind, placebo controlled study of LCQ908 in subjects with Familial Chylomicronemia Syndrome
Principle Investigator
Subramanian, Savitha
Contact
Houser, Kathryn (Kay)
khouser@uw.edu (206) 744-9117